Covance, a provider of drug development services, has closed its transaction with Eli Lilly and Company to provide a broad-range of drug development services over the next 10 years and to purchase Lilly's 450-acre early drug development campus in Greenfield, Indiana.
Subscribe to our email newsletter
Effective immediately, Covance will assume control of the Greenfield campus and 264 Lilly employees will be working for Covance.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.